Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
Division of Cancer Prevention and Control, University of Colorado Cancer Center, Aurora, CO, USA.
Psychooncology. 2018 May;27(5):1434-1441. doi: 10.1002/pon.4526. Epub 2017 Sep 18.
Cancer survivor preferences for formal interventions designed to provide psychological support remain relatively unknown. To address this gap, we evaluated cancer survivors' preferences for psychological intervention, whom they preferred to recommend such intervention, and how their preferences compared with what they currently received.
US cancer survivors (n = 345) who were at least 2 months post-treatment for diverse forms of cancer were recruited online to complete a survey study.
Based on Wilcoxon signed-rank tests to distinguish among ranked preferences, cancer survivors rated individual professional counseling as their most-preferred form of psychological intervention (among 6 choices), p < .001, followed by professionally led cancer support groups and individual peer counseling. Anti-depressant or other psychiatric medication represented their least-preferred intervention, ps < .001, but was the one they were most likely to currently receive. Preference for individual professional counseling over psychiatric medication was evident even among the subgroups of cancer survivors screening positively for probable anxiety disorder (n = 188) or major depression (n = 137), ps < .001. Cancer survivors most preferred to learn about psychological interventions from their medical oncologist, p < .001, followed by primary care physician, cancer nurse, or another cancer survivor; they least preferred to learn from a social worker or on their own, ps < .001.
Cancer survivors reported significant unmet need for psychological intervention, preference for non-pharmacological forms of such support, and a gap between their preferred forms of support and what they currently receive.
癌症幸存者对旨在提供心理支持的正式干预措施的偏好仍相对未知。为了解决这一差距,我们评估了癌症幸存者对心理干预的偏好、他们希望谁来推荐这种干预,以及他们的偏好与他们目前所接受的干预有何不同。
我们在线招募了 345 名美国癌症幸存者,他们在接受不同形式的癌症治疗后至少 2 个月。
基于 Wilcoxon 符号秩检验来区分排名偏好,癌症幸存者将个体专业咨询评为他们最偏好的心理干预形式(在 6 种选择中),p<0.001,其次是专业领导的癌症支持小组和个体同伴咨询。抗抑郁药或其他精神科药物是他们最不偏好的干预措施,p<0.001,但也是他们最有可能目前正在接受的干预措施。即使在筛查出可能患有焦虑症(n=188)或重度抑郁症(n=137)的癌症幸存者亚组中,个体专业咨询对精神科药物的偏好也很明显,p<0.001。癌症幸存者最希望从他们的肿瘤医生那里了解心理干预措施,p<0.001,其次是初级保健医生、癌症护士或其他癌症幸存者;他们最不希望从社会工作者或自己那里了解,p<0.001。
癌症幸存者报告了对心理干预的显著未满足需求,偏好非药物形式的支持,以及他们所偏好的支持形式与他们目前所接受的支持之间存在差距。